Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

Chronic obstructive pulmonary disease (COPD) presents a significant challenge for both patients and health care providers and discussions of effective management strategies took center stage at CHEST ...

Two posters presented at the CHEST 2024 annual meeting underscore the importance of early identification and treatment of ...

“We’re trying to treat conditions like asthma and COPD with these inhalers, and we’re actually making it harder to breathe,” said Jyothi Tirumalasetty, a clinical assistant professor at ...

Albuterol inhalers are life-saving devices used by those with asthma and Chronic Obstructive Pulmonary Disease (COPD). Globally, as many as 384 million people suffer from COPD – the third leading ...

Digital dose inhalers are crucial in enhancing medication adherence and monitoring for patients diagnosed with asthma and chronic obstructive pulmonary disease (COPD). Make Your Report Purchase ...

It is used for the management of chronic COPD and it can be used as a rescue inhaler as well. It is available as a 45 mcg aerosol or a nebulizer (0.31 mg/3 mL, 0.63 mg/3 mL, 1.25 mg/3 mL, or 1.25 ...

Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...

Learn how dupilumab significantly improves quality of life in COPD patients with type 2 inflammation, according to phase 3 ...

While people with asthma or chronic obstructive pulmonary disease (COPD ... companies are looking to change that with lower-emitting inhalers that they plan to roll out by the end of the decade.

Extrafine single inhaler triple therapy is effective among patients with COPD who were previously treated with multiple-inhaler triple therapy.

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.